ramé-hart, inc. Company Profile

13:56 EST 17th December 2018 | BioPortfolio

For over 45 years, ramé-hart has been the pioneer and premier manufacturer of contact angle goniometers and tensiometers. ramé-hart instrument company is the largest company in the world dedicated solely to the production, sales, and support of contact angle tools.

Our array of time-tested designs suit practically every research and QC environment. When our standard products do not meet our customer's requirements, we build custom instruments and fixtures.

Over the past four decades, ramé-hart has built thousands of Contact Angle Goniometers -- many are still in use today. We service and upgrade legacy instruments to extend the investments of our customers. We also offer a compelling lineup of current-generation instruments which employ the latest and most advantageous technological innovations.

At ramé-hart instrument co. we are dedicated to 100% customer satisfaction. All of our tools come with a iron-clad warranty and are backed by our rich heritage and expert experience.

Goniometer spare parts can be ordered online.


PO Box 400
New Jersey
United States of America


Phone: 973-448-0305
Fax: 973-448-0315

News Articles [29 Associated News Articles listed on BioPortfolio]

Hart Recaps Data With Abemaciclib in HR+/HER2- Breast Cancer

Abemaciclib (Verzenio) has emerged as a promising agent for patients with hormone receptor-positive, HER2-negative metastatic breast cancer, according to Lowell L. Hart, MD.

Sutton Hart Press Acquires cannabis business book by David Kani Tony Alfiere

VANCOUVER, Wash., Sept. 15, 2018 /PRNewswire/ -- Sutton Hart Press has acquired worldwide rights to POT INC. authored by California cannabis business trial lawyer David Read more...

New tests accurately detect heart disease and adverse cardiac events in diabetic patients

Prevencio, Inc. today announces data which indicates its HART CAD and HART CVE tests accurately diagnose Coronary Artery Disease and risk for Major Adverse Cardiac Events in Diabetic Mellitus patients...

Derek Nigel John Hart (1952–2017)

Prevencio's HART PAD test detects PAD in diabetes patients

Avid Bioservices Announces Appointment of Daniel Hart as Chief Financial Officer

-- Senior Executive with Extensive Financial Leadership Experience Further Strengthens Management Team; Company Also Adds Senior Director of Business Development for Western Region to Support Client ...

An inverse care law for our time

“We are still able to do the most civilized thing in the world—put the welfare of the sick in front of every other consideration.” Julian Tudor Hart begins his book on his credo as a general... ...

Avid Bioservices Appoints CFO

Daniel Hart will be responsible for overseeing and managing all of Avid’s accounting and finance responsibilities

Drugs and Medications [0 Results]


PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).

Maximal safe surgical resection followed by adjuvant chemoradiation has been standard for newly diagnosed glioblastoma multiforme (GBM). Hypofractionated accelerated radiotherapy (HART) has the potent...

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.

The I HART CGM study showed that real-time continuous glucose monitoring (RT-CGM) has greater beneficial impact on hypoglycemia than intermittent flash glucose monitoring (flash) in adults with type 1...

An update and expansion on the role of the Violence Risk Appraisal Guide and Historical Clinical Risk Management-20 in United States case law.

An individual's risk for future violent behavior may be considered in various legal contexts, including civil commitment, criminal sentencing, or suitability for parole. Among the assessment tools for...

Language Does Matter: But There is More to Language Than Vocabulary and Directed Speech.

In response to Golinkoff, Hoff, Rowe, Tamis-LeMonda, and Hirsh-Pasek's (2018) commentary, we clarify our goals, outline points of agreement and disagreement between our respective positions, and addre...

Language Matters: Denying the Existence of the 30-Million-Word Gap Has Serious Consequences.

Sperry, Sperry, and Miller (2018) aim to debunk what is called the 30-million-word gap by claiming that children from lower income households hear more speech than Hart and Risley () reported. We addr...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Healthy Aging Resources to Thrive (HART)

Healthy Aging Resources to Thrive (HART) uses a rigorous two-stage randomized control design, adapted and refined based on pilot studies, to test a novel intervention to reduce sitting tim...

Evaluation of Haitian American Responsible Teens

The Haitian American Responsible Teen (HART) afterschool program, a cultural adaptation of the BART curriculum, will provide an HIV/AIDS curriculum adapted to Haitian students that consist...

Montreal Heart Attack Readjustment Trial (M-HART)

To examine the impact of a monitoring and social support intervention upon survival of myocardial infarction patients.

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Aim: To improve curability of radiotherapy in HNSCC patients identified by hypoxic FAZA-PET scanning

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

To determine the effects, in postmenopausal women, of hormone replacement therapy on progression/regression of coronary heart disease, as measured by quantitative angiography.

Companies [13 Associated Companies listed on BioPortfolio]

ramé-hart, inc.

For over 45 years, ramé-hart has been the pioneer and premier manufacturer of contact angle goniometers and tensiometers. ramé-hart instrument company is the largest company in the world dedicated s...

Calorimetry Sciences Corp.

In 1978 Hart Scientific, Inc. was founded to commercialize instruments which had been developed in academia and make them readily available to research institutions.The company began a very rapid grow...

Prevencio, Inc.

Prevencio, a development stage company, is pioneering multiplex proteomic cardiac biomarker diagnostic tests for ruling out obstructive coronary artery disease in chest pain patie...

HART Health


Hart Energy Publishing

More Information about "ramé-hart, inc." on BioPortfolio

We have published hundreds of ramé-hart, inc. news stories on BioPortfolio along with dozens of ramé-hart, inc. Clinical Trials and PubMed Articles about ramé-hart, inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ramé-hart, inc. Companies in our database. You can also find out about relevant ramé-hart, inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record